A Study to Evaluate the Impact of Upadacitinib on Spondyloarthritis Outcomes in Patients With Active Psoriatic Arthritis
Phase 4
Recruiting
- Conditions
- Psoriatic ArthritisSpondyloarthritis, Axial
- Interventions
- Drug: Placebo
- First Posted Date
- 2024-06-12
- Last Posted Date
- 2025-02-12
- Lead Sponsor
- CARE ARTHRITIS LTD.
- Target Recruit Count
- 100
- Registration Number
- NCT06454188
- Locations
- 🇺🇸
DM Clinical Research, Tomball, Texas, United States
🇨🇦The Ottawa Hospital Research Institute, Ottawa, Ontario, Canada
🇨🇦Groupe de Recherche en Maladies Osseuses (G.R.M.O.) Inc., Québec, Canada
Osteoarthritis of the Knee, Inflammation, and the Effect of Adalimumab (OKINADA)
- First Posted Date
- 2015-06-15
- Last Posted Date
- 2021-10-27
- Lead Sponsor
- CARE ARTHRITIS LTD.
- Target Recruit Count
- 62
- Registration Number
- NCT02471118
- Locations
- 🇨🇦
Western University, London, Ontario, Canada
🇨🇦Division of Rheumatology, University of Alberta Hospital, Edmonton, Alberta, Canada
🇨🇦A.M.I.R., Montréal, Quebec, Canada
Assess Structural Damage in Rheumatoid Arthritis Using Biomarkers and Radiography
Completed
- Conditions
- Rheumatoid Arthritis
- Interventions
- Other: Observational study
- First Posted Date
- 2011-11-22
- Last Posted Date
- 2021-10-27
- Lead Sponsor
- CARE ARTHRITIS LTD.
- Target Recruit Count
- 571
- Registration Number
- NCT01476956
- Locations
- 🇺🇸
Division of Rheumatology, Columbia University, College of Physicians and Surgeons, New York, New York, United States
🇺🇸Johns Hopkins Arthritis Center, Johns Hopkins University, Baltimore, Maryland, United States
🇺🇸Seattle Rheumatology Associates, Seattle, Washington, United States
© Copyright 2025. All Rights Reserved by MedPath